DETECTION OF A TARGET IN A SAMPLE
    41.
    发明申请
    DETECTION OF A TARGET IN A SAMPLE 审中-公开
    在样品中检测目标

    公开(公告)号:US20120309106A1

    公开(公告)日:2012-12-06

    申请号:US13197294

    申请日:2011-08-03

    CPC classification number: C12Q1/6825 C12Q1/6816 C12Q1/6834 G01N33/5438

    Abstract: The invention concerns a system, device, kit and method for detecting the presence, or concentration of a target in a sample. An assay set comprising at least two spaced apart electrodes is used, comprising a recognition moiety, capable of specific binding to the target, which is attached to at least one of the electrodes or the substrate therein between. If the recognition moiety binds the target then a conductive bridge can be formed between the electrodes, based on the complex between the recognition moiety and the target. The conductive bridge is formed by using nucleation-center forming entities attached to the complexes or to the targets from which a conductive substance is substantially grown. Alternatively the conducting bridge forms a conductive polymer between the electrodes.

    Abstract translation: 本发明涉及一种用于检测样品中靶的存在或浓度的系统,装置,试剂盒和方法。 使用包含至少两个间隔开的电极的测定组,其包含能够特异性结合靶的识别部分,其连接到其中的至少一个电极或其中的基底。 如果识别部分结合靶,则可以基于识别部分和靶之间的复合物在电极之间形成导电桥。 导电桥是通过使用连接到复合物或基本上生长导电物质的靶的成核中心形成实体形成的。 或者,导电桥在电极之间形成导电聚合物。

    MODULATION OF GLUT4 GENE PROMOTER ACTIVITY BY AHNAK
    43.
    发明申请
    MODULATION OF GLUT4 GENE PROMOTER ACTIVITY BY AHNAK 审中-公开
    通过AHNAK调节GLUT4基因启动子活性

    公开(公告)号:US20120208863A1

    公开(公告)日:2012-08-16

    申请号:US13442918

    申请日:2012-04-10

    Abstract: Agents capable of alleviating AHNAK phosphoprotein-mediated repression of GLUT4 gene expression are useful for prevention, treatment, and/or alleviation of insulin resistance associated with obesity, lipotoxicity, hypertension, metabolic syndrome and type 2 diabetes. Preferred agents are double-stranded siRNAs.

    Abstract translation: 能够减轻AHNAK磷蛋白介导的GLUT4基因表达抑制的试剂可用于预防,治疗和/或减轻与肥胖,脂毒性,高血压,代谢综合征和2型糖尿病相关的胰岛素抵抗。 优选的试剂是双链siRNA。

    FABRICATION OF HOLLOW NANONEEDLES
    44.
    发明申请
    FABRICATION OF HOLLOW NANONEEDLES 审中-公开
    中空纳米线的制造

    公开(公告)号:US20120171755A1

    公开(公告)日:2012-07-05

    申请号:US13338831

    申请日:2011-12-28

    Inventor: Elad Peer Uri Sivan

    CPC classification number: C12M35/00

    Abstract: The present invention provides a method of fabricating a device having hollow nanoneedles which extend through a supporting membrane. The device can be used as a molecular delivery system.5

    Abstract translation: 本发明提供一种制造延伸穿过支撑膜的中空纳米针的装置的方法。 该装置可用作分子递送系统。 5

    UAV decision and control system
    45.
    发明授权
    UAV decision and control system 有权
    无人机决策和控制系统

    公开(公告)号:US08186589B2

    公开(公告)日:2012-05-29

    申请号:US12160779

    申请日:2007-01-10

    CPC classification number: G05D1/104 G05D1/0088

    Abstract: The present invention relates to a hierarchical system and method for task assignment (TA), coordination and communication of multiple Unmanned Aerial Vehicles (DAV's) engaging multiple attack targets and conceives an ad-hoc routing algorithm for synchronization of target lists utilizing a distributed computing topology. Assuming limited communication bandwidth and range, coordination of UAV motion is achieved by implementing a simple behavioral flocking algorithm utilizing a tree topology for target list routing. The TA algorithm is based on a graph-theoretic approach, in which a node locates all the detectable targets, identifies them and computes its distance to each target. The node then produces an attack plan that minimizes the sum of distances of the UAV's in the subtree of a given node to the targets.

    Abstract translation: 本发明涉及一种用于任务分配(TA)的分层系统和方法,涉及多个攻击目标的多个无人驾驶飞行器(DAV)的协调和通信,并且构思了利用分布式计算拓扑来同步目标列表的自组织路由算法 。 假设有限的通信带宽和范围,UAV运动的协调是通过使用用于目标列表路由的树形拓扑的简单行为植入算法来实现的。 TA算法基于图理论方法,其中节点定位所有可检测的目标,识别它们并计算其到每个目标的距离。 该节点然后产生一个攻击计划,最小化给定节点的子任务中的UAV在目标上的距离之和。

    SOLUBLE HLA COMPLEXES FOR USE IN DISEASE DIAGNOSIS
    46.
    发明申请
    SOLUBLE HLA COMPLEXES FOR USE IN DISEASE DIAGNOSIS 审中-公开
    可溶性HLA复合物用于疾病诊断

    公开(公告)号:US20120077696A1

    公开(公告)日:2012-03-29

    申请号:US13256712

    申请日:2010-03-14

    CPC classification number: G01N33/56977 G01N33/57484

    Abstract: The invention relates to diagnostic kits, methods of diagnosing, prognosing and staging diseases, and immunogenic compositions. The invention is based on the detection of peptides associated with circulating soluble HLA complexes in particular disease states, including malignant diseases.

    Abstract translation: 本发明涉及诊断试剂盒,诊断,预后和分期疾病的方法以及免疫原性组合物。 本发明基于与循环可溶性HLA复合物,特别是疾病状态(包括恶性疾病)相关的肽的检测。

    Apparatus and method for excitation of a single mode in a waveguide
    49.
    发明授权
    Apparatus and method for excitation of a single mode in a waveguide 有权
    波导中单模激发的装置和方法

    公开(公告)号:US08045830B2

    公开(公告)日:2011-10-25

    申请号:US12438754

    申请日:2007-08-28

    Applicant: Erez Hasman

    Inventor: Erez Hasman

    CPC classification number: G02B6/102 G02B6/4204

    Abstract: A wave-guiding system and method for mode-selective transmission of a spatially coherent light beam is disclosed. The system comprises a wave-guide with an inlet and an outlet for transmitting one or more modes; a first mode-shaping optical element for shaping the spatially coherent light beam before it enters through the inlet of the wave-guide to a desired mode of the wave-guide; and a second mode-shaping optical element for shaping light beam after it exits from the outlet of the wave-guide for obtaining a desired vectorial field.

    Abstract translation: 公开了一种用于空间相干光束的模式选择性传输的波导系统和方法。 该系统包括具有用于传输一种或多种模式的入口和出口的波导; 第一模式整形光学元件,用于在空间相干光束通过波导的入口进入波导的所需模式之前成形; 以及用于在光束从波导的出口离开之后成形光束以获得期望的矢量场的第二模式整形光学元件。

    POLYMER-CONJUGATED ALBUMIN HYDROGELS FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS
    50.
    发明申请
    POLYMER-CONJUGATED ALBUMIN HYDROGELS FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS 有权
    用于控制释放治疗药物的聚合物结合的氢溴酸盐

    公开(公告)号:US20110238000A1

    公开(公告)日:2011-09-29

    申请号:US13133241

    申请日:2009-12-07

    CPC classification number: A61K9/0024 A61K31/37 A61K47/42 A61K47/6903

    Abstract: A hydrogel system comprising polymer-conjugated albumin molecules is provided for controlled release delivery of therapeutic agents. The polymer is a functionalized synthetic polymer, preferably PEG-diacrylate. The polymer-conjugated albumin is preferably mono-PEGylated albumin. The hydrogel system may comprise a matrix to which the polymer-conjugated albumin molecules are linked via a functional group of the polymer. The matrix may be formed from the same polymer of the polymer-albumin conjugate.

    Abstract translation: 提供包含聚合物共轭白蛋白分子的水凝胶体系用于治疗剂的控制释放递送。 聚合物是官能化的合成聚合物,优选PEG-二丙烯酸酯。 聚合物结合的白蛋白优选是单PEG化的白蛋白。 所述水凝胶体系可以包含基质,所述聚合物结合的白蛋白分子通过所述聚合物的官能团连接到基质上。 基质可以由聚合物 - 白蛋白缀合物的相同聚合物形成。

Patent Agency Ranking